APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bicyclic Peptide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bicyclic Peptide Industry Growth and Trends Forecast to 2032

30 December 202573 pages

Choose your research edition.

Industry ResearchBicyclic Peptide Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Bicyclic Peptide Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Bicyclic Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bicyclic Peptide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Bicyclic Peptide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bicyclic Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bicyclic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bicyclic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bicyclic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bicyclic Peptide include Creative Peptides, Genscript, JPT Peptide Technologies and Hongtide, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bicyclic Peptide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bicyclic Peptide market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bicyclic Peptide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bicyclic Peptide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bicyclic Peptide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bicyclic Peptide Market by Company

Creative Peptides

Genscript

JPT Peptide Technologies

Hongtide

Bicyclic Peptide Segment by Type

Heterocyclic Bicyclic Peptides

Homocyclic Bicyclic Peptides

Bicyclic Peptide Segment by Application

Neurogenic Activity

Antibacterial

Antitumor

Other

Bicyclic Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicyclic Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bicyclic Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicyclic Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bicyclic Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bicyclic Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Heterocyclic Bicyclic Peptides Table 2. Major Company of Homocyclic Bicyclic Peptides Table 3. Global Bicyclic Peptide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 5. Global Bicyclic Peptide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bicyclic Peptide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bicyclic Peptide Sales Market Share in Value by Type (2021-2026) Table 8. Global Bicyclic Peptide Price by Type (2021-2026) & (US$/g) Table 9. Global Bicyclic Peptide Sales by Type (2027-2032) & (Kg) Table 10. Global Bicyclic Peptide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bicyclic Peptide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bicyclic Peptide Sales Market Share in Value by Type (2027-2032) Table 13. Global Bicyclic Peptide Price by Type (2027-2032) & (US$/g) Table 14. North America Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 15. North America Bicyclic Peptide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 17. Europe Bicyclic Peptide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Bicyclic Peptide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 21. Latin America Bicyclic Peptide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Bicyclic Peptide Sales by Type (2021-2026) & (US$ Million) Table 24. Bicyclic Peptide Industry Trends Table 25. Bicyclic Peptide Industry Drivers Table 26. Bicyclic Peptide Industry Opportunities and Challenges Table 27. Bicyclic Peptide Industry Restraints Table 28. Global Bicyclic Peptide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bicyclic Peptide Revenue Market Share by Company (2021-2026) Table 30. Global Bicyclic Peptide Sales by Company (2021-2026) & (Kg) Table 31. Global Bicyclic Peptide Sales Share by Company (2021-2026) Table 32. Global Bicyclic Peptide Market Price by Company (2021-2026) & (US$/g) Table 33. Global Bicyclic Peptide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bicyclic Peptide Major Company Production Sites and Headquarters Table 35. Global Bicyclic Peptide Company, Product Type & Application Table 36. Global Bicyclic Peptide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bicyclic Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bicyclic Peptide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bicyclic Peptide Sales by Region (2021-2026) & (Kg) Table 41. Global Bicyclic Peptide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bicyclic Peptide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bicyclic Peptide Sales Market Share in Value by Region (2021-2026) Table 44. Global Bicyclic Peptide Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Bicyclic Peptide Sales by Region (2027-2032) & (Kg) Table 46. Global Bicyclic Peptide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bicyclic Peptide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bicyclic Peptide Sales Market Share in Value by Region (2027-2032) Table 49. Global Bicyclic Peptide Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Bicyclic Peptide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 52. Global Bicyclic Peptide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bicyclic Peptide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bicyclic Peptide Sales Market Share in Value by Application (2021-2026) Table 55. Global Bicyclic Peptide Price by Application (2021-2026) & (US$/g) Table 56. Global Bicyclic Peptide Sales by Application (2027-2032) & (Kg) Table 57. Global Bicyclic Peptide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bicyclic Peptide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bicyclic Peptide Sales Market Share in Value by Application (2027-2032) Table 60. Global Bicyclic Peptide Price by Application (2027-2032) & (US$/g) Table 61. North America Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 62. North America Bicyclic Peptide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 64. Europe Bicyclic Peptide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Bicyclic Peptide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 68. Latin America Bicyclic Peptide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Bicyclic Peptide Sales by Application (2021-2026) & (US$ Million) Table 71. Creative Peptides Company Information Table 72. Creative Peptides Business Overview Table 73. Creative Peptides Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Creative Peptides Bicyclic Peptide Product Portfolio Table 75. Creative Peptides Recent Development Table 76. Genscript Company Information Table 77. Genscript Business Overview Table 78. Genscript Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Genscript Bicyclic Peptide Product Portfolio Table 80. Genscript Recent Development Table 81. JPT Peptide Technologies Company Information Table 82. JPT Peptide Technologies Business Overview Table 83. JPT Peptide Technologies Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. JPT Peptide Technologies Bicyclic Peptide Product Portfolio Table 85. JPT Peptide Technologies Recent Development Table 86. Hongtide Company Information Table 87. Hongtide Business Overview Table 88. Hongtide Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Hongtide Bicyclic Peptide Product Portfolio Table 90. Hongtide Recent Development Table 91. North America Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 92. North America Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 93. North America Bicyclic Peptide Sales Market Share by Country (2021-2026) Table 94. North America Bicyclic Peptide Sales Forecast by Country (2027-2032) & (Kg) Table 95. North America Bicyclic Peptide Sales Market Share Forecast by Country (2027-2032) Table 96. North America Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Bicyclic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Bicyclic Peptide Market Share by Country (2021-2026) Table 99. North America Bicyclic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Bicyclic Peptide Market Share Forecast by Country (2027-2032) Table 101. Europe Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 102. Europe Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 103. Europe Bicyclic Peptide Sales Market Share by Country (2021-2026) Table 104. Europe Bicyclic Peptide Sales Forecast by Country (2027-2032) & (Kg) Table 105. Europe Bicyclic Peptide Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Bicyclic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Bicyclic Peptide Market Share by Country (2021-2026) Table 109. Europe Bicyclic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Bicyclic Peptide Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 113. Asia-Pacific Bicyclic Peptide Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Bicyclic Peptide Sales Forecast by Country (2027-2032) & (Kg) Table 115. Asia-Pacific Bicyclic Peptide Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Bicyclic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Bicyclic Peptide Market Share by Country (2021-2026) Table 119. Asia-Pacific Bicyclic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Bicyclic Peptide Market Share Forecast by Country (2027-2032) Table 121. Latin America Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. Latin America Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 123. Latin America Bicyclic Peptide Sales Market Share by Country (2021-2026) Table 124. Latin America Bicyclic Peptide Sales Forecast by Country (2027-2032) & (Kg) Table 125. Latin America Bicyclic Peptide Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Bicyclic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Bicyclic Peptide Market Share by Country (2021-2026) Table 129. Latin America Bicyclic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Bicyclic Peptide Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 133. Middle East and Africa Bicyclic Peptide Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Bicyclic Peptide Sales Forecast by Country (2027-2032) & (Kg) Table 135. Middle East and Africa Bicyclic Peptide Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Bicyclic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Bicyclic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Bicyclic Peptide Market Share by Country (2021-2026) Table 139. Middle East and Africa Bicyclic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Bicyclic Peptide Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Bicyclic Peptide Distributors List Table 144. Bicyclic Peptide Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Bicyclic Peptide Image Figure 2. Global Bicyclic Peptide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicyclic Peptide Market Size (2021-2032) & (US$ Million) Figure 4. Global Bicyclic Peptide Sales (2021-2032) & (Kg) Figure 5. Heterocyclic Bicyclic Peptides Image Figure 6. Global Heterocyclic Bicyclic Peptides Sales YoY Growth (2021-2032) & (Kg) Figure 7. Homocyclic Bicyclic Peptides Image Figure 8. Global Homocyclic Bicyclic Peptides Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Bicyclic Peptide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bicyclic Peptide Market Share by Type 2025 VS 2032 Figure 11. North America Bicyclic Peptide Sales Market Share in Volume by Type in 2025 Figure 12. North America Bicyclic Peptide Sales Market Share in Value by Type in 2025 Figure 13. Europe Bicyclic Peptide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bicyclic Peptide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bicyclic Peptide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bicyclic Peptide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bicyclic Peptide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bicyclic Peptide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bicyclic Peptide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bicyclic Peptide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bicyclic Peptide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Neurogenic Activity Image Figure 24. Global Neurogenic Activity Sales YoY Growth (2021-2032) & (Kg) Figure 25. Antibacterial Image Figure 26. Global Antibacterial Sales YoY Growth (2021-2032) & (Kg) Figure 27. Antitumor Image Figure 28. Global Antitumor Sales YoY Growth (2021-2032) & (Kg) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Bicyclic Peptide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Bicyclic Peptide Market Share by Application 2025 VS 2032 Figure 33. North America Bicyclic Peptide Sales Market Share in Volume by Application in 2025 Figure 34. North America Bicyclic Peptide Sales Market Share in Value by Application in 2025 Figure 35. Europe Bicyclic Peptide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Bicyclic Peptide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Bicyclic Peptide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Bicyclic Peptide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Bicyclic Peptide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Bicyclic Peptide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Bicyclic Peptide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Bicyclic Peptide Sales Market Share in Value by Application in 2025 Figure 43. North America Bicyclic Peptide Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Bicyclic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Bicyclic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Bicyclic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bicyclic Peptide Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Bicyclic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bicyclic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Bicyclic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bicyclic Peptide Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Bicyclic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bicyclic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Bicyclic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bicyclic Peptide Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Bicyclic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bicyclic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Bicyclic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bicyclic Peptide Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Bicyclic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bicyclic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Bicyclic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Bicyclic Peptide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Bicyclic Peptide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Heterocyclic Bicyclic Peptides
  • Homocyclic Bicyclic Peptides
Applications
  • Neurogenic Activity
  • Antibacterial
  • Antitumor
  • Other
Companies covered
  • Creative Peptides
  • Genscript
  • JPT Peptide Technologies
  • Hongtide

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bicyclic Peptide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bicyclic Peptide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bicyclic Peptide Market by Type
  6. 1.3.1 Heterocyclic Bicyclic Peptides
  7. 1.3.2 Homocyclic Bicyclic Peptides
  8. 1.4 Global Bicyclic Peptide Market Size by Type
  9. 1.4.1 Global Bicyclic Peptide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bicyclic Peptide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bicyclic Peptide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bicyclic Peptide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bicyclic Peptide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bicyclic Peptide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bicyclic Peptide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bicyclic Peptide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bicyclic Peptide Industry Trends
  2. 2.2 Bicyclic Peptide Industry Drivers
  3. 2.3 Bicyclic Peptide Industry Opportunities and Challenges
  4. 2.4 Bicyclic Peptide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bicyclic Peptide Revenue (2021-2026)
  2. 3.2 Global Top Players by Bicyclic Peptide Sales (2021-2026)
  3. 3.3 Global Top Players by Bicyclic Peptide Price (2021-2026)
  4. 3.4 Global Bicyclic Peptide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bicyclic Peptide Major Company Production Sites & Headquarters
  6. 3.6 Global Bicyclic Peptide Company, Product Type & Application
  7. 3.7 Global Bicyclic Peptide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bicyclic Peptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bicyclic Peptide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bicyclic Peptide Tier 1, Tier 2, and Tier 3
4 Bicyclic Peptide Regional Status and Outlook
  1. 4.1 Global Bicyclic Peptide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bicyclic Peptide Historic Market Size by Region
  3. 4.2.1 Global Bicyclic Peptide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bicyclic Peptide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bicyclic Peptide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bicyclic Peptide Forecasted Market Size by Region
  7. 4.3.1 Global Bicyclic Peptide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bicyclic Peptide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bicyclic Peptide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bicyclic Peptide by Application
  1. 5.1 Bicyclic Peptide Market by Application
  2. 5.1.1 Neurogenic Activity
  3. 5.1.2 Antibacterial
  4. 5.1.3 Antitumor
  5. 5.1.4 Other
  6. 5.2 Global Bicyclic Peptide Market Size by Application
  7. 5.2.1 Global Bicyclic Peptide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Bicyclic Peptide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Bicyclic Peptide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Bicyclic Peptide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Bicyclic Peptide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Bicyclic Peptide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Bicyclic Peptide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Bicyclic Peptide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Creative Peptides
  2. 6.1.1 Creative Peptides Company Information
  3. 6.1.2 Creative Peptides Business Overview
  4. 6.1.3 Creative Peptides Bicyclic Peptide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Creative Peptides Bicyclic Peptide Product Portfolio
  6. 6.1.5 Creative Peptides Recent Developments
  7. 6.2 Genscript
  8. 6.2.1 Genscript Company Information
  9. 6.2.2 Genscript Business Overview
  10. 6.2.3 Genscript Bicyclic Peptide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Genscript Bicyclic Peptide Product Portfolio
  12. 6.2.5 Genscript Recent Developments
  13. 6.3 JPT Peptide Technologies
  14. 6.3.1 JPT Peptide Technologies Company Information
  15. 6.3.2 JPT Peptide Technologies Business Overview
  16. 6.3.3 JPT Peptide Technologies Bicyclic Peptide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 JPT Peptide Technologies Bicyclic Peptide Product Portfolio
  18. 6.3.5 JPT Peptide Technologies Recent Developments
  19. 6.4 Hongtide
  20. 6.4.1 Hongtide Company Information
  21. 6.4.2 Hongtide Business Overview
  22. 6.4.3 Hongtide Bicyclic Peptide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hongtide Bicyclic Peptide Product Portfolio
  24. 6.4.5 Hongtide Recent Developments
7 North America by Country
  1. 7.1 North America Bicyclic Peptide Sales by Country
  2. 7.1.1 North America Bicyclic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bicyclic Peptide Sales by Country (2021-2026)
  4. 7.1.3 North America Bicyclic Peptide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bicyclic Peptide Market Size by Country
  6. 7.2.1 North America Bicyclic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bicyclic Peptide Market Size by Country (2021-2026)
  8. 7.2.3 North America Bicyclic Peptide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bicyclic Peptide Sales by Country
  2. 8.1.1 Europe Bicyclic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bicyclic Peptide Sales by Country (2021-2026)
  4. 8.1.3 Europe Bicyclic Peptide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bicyclic Peptide Market Size by Country
  6. 8.2.1 Europe Bicyclic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bicyclic Peptide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bicyclic Peptide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bicyclic Peptide Sales by Country
  2. 9.1.1 Asia-Pacific Bicyclic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bicyclic Peptide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bicyclic Peptide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bicyclic Peptide Market Size by Country
  6. 9.2.1 Asia-Pacific Bicyclic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bicyclic Peptide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bicyclic Peptide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bicyclic Peptide Sales by Country
  2. 10.1.1 South America Bicyclic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bicyclic Peptide Sales by Country (2021-2026)
  4. 10.1.3 South America Bicyclic Peptide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bicyclic Peptide Market Size by Country
  6. 10.2.1 South America Bicyclic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bicyclic Peptide Market Size by Country (2021-2026)
  8. 10.2.3 South America Bicyclic Peptide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bicyclic Peptide Sales by Country
  2. 11.1.1 Middle East and Africa Bicyclic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bicyclic Peptide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bicyclic Peptide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bicyclic Peptide Market Size by Country
  6. 11.2.1 Middle East and Africa Bicyclic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bicyclic Peptide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bicyclic Peptide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bicyclic Peptide Value Chain Analysis
  2. 12.1.1 Bicyclic Peptide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bicyclic Peptide Production Mode & Process
  7. 12.2 Bicyclic Peptide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bicyclic Peptide Distributors
  10. 12.2.3 Bicyclic Peptide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst